Pharmaceutical distributor McKesson (NYSE: MCK) remains in the spotlight for its role in the opioid epidemic. Earlier this month, McKesson agreed to settle a lawsuit with the state of West Virginia for $37 million. The lawsuit claimed that the company flooded the market with highly addictive narcotics and misled the public. This is just one of a multitude of settlements we expect McKesson to pay going forward. McKesson estimates opioid litigation alone will cost it $100 million in 2019 and $150 million per year starting in 2020. This litigation will only grow from here.
First posted on Facebook https://www.facebook.com/groups/rhosignals/
All posts and charts are for educational and illustration purposes only
Post a Comment
Note: Only a member of this blog may post a comment.